LiDCO Offers Clinicians, for the First Time, a Board-in-Cable Solution Designed to Provide a More Complete Picture of Oxygen Delivery NEUCHATEL, Switzerland--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) ...

Connected care company Masimo has landed and expanded FDA clearance for its O3 Regional Oximeter, for both somatic applications and monitoring changes in the cerebral hemoglobin. It specifically ...

Masimo MASI recently secured FDA 510(k) clearance for expanded indications of its O3 Regional Oximetry with delta hemoglobin parameters. These parameters track relative changes in hemoglobin levels, ...

Noting that traditional methods of measuring hemoglobin and estimating blood loss as part of perioperative blood transfusion management are “time consuming” and may cause delays in decision making, ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that the Masimo W1™ medical watch has received FDA 510(k) clearance for over-the-counter (OTC) and prescription use (Rx). Masimo ...

Now Available for Both Cerebral and Somatic Applications and for All Patient Populations, O3’s Delta Hemoglobin Parameters Offer Clinicians Additional Insight Into Changes in Tissue Oxygen Saturation ...

During a Nov. 5 webinar hosted by Becker’s Healthcare Review and sponsored by Masimo, UC Irvine Health System’s CMO discussed an innovative, noninvasive care approach for critically ill patients. 1.

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the release of MX-7™, its latest and most advanced rainbow SET ® board. Designed for integration into the more than 200 ...

Apple convinced a federal jury on Friday that health monitoring tech company Masimo’s smartwatches infringe two of its design patents. The jury, in Delaware, agreed with Apple that Masimo’s W1 and ...

Nov 15 (Reuters) - Masimo Corp , a maker of non-invasive patient monitoring products, told U.S. regulators that it received allegations about the safety and efficacy of its hemoglobin testing products ...